RRR

RESONANCE HEALTH LIMITED

No trades
See on Supercharts
Market capitalization
‪37.99 M‬AUD
−0.002AUD
‪−780.36 K‬AUD
‪4.40 M‬AUD
‪374.99 M‬
Beta (1Y)
0.36

About RESONANCE HEALTH LIMITED

CEO
Andrew Duncan Harrison
Headquarters
Burswood
Founded
1987
ISIN
AU000000RHT2
FIGI
BBG000BWR5D1
Resonance Health Ltd. operates as a healthcare company, which involves in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. It operates through the following segments: Services, Corporate, Research and Development. The company was founded by Santino Di-Giacomo in 1987 and is headquartered in Burswood, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RHT is 0.081 AUD — it has decreased by 4.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange RESONANCE HEALTH LIMITED stocks are traded under the ticker RHT.
RHT stock is 4.94% volatile and has beta coefficient of 0.36. Check out the list of the most volatile stocks — is RESONANCE HEALTH LIMITED there?
Yes, you can track RESONANCE HEALTH LIMITED financials in yearly and quarterly reports right on TradingView.
RHT stock has risen by 1.25% compared to the previous week, the month change is a 28.57% rise, over the last year RESONANCE HEALTH LIMITED has showed a 68.75% increase.
RHT net income for the last quarter is ‪−557.55 K‬ AUD, while the quarter before that showed ‪−528.57 K‬ AUD of net income which accounts for −5.48% change. Track more RESONANCE HEALTH LIMITED financial stats to get the full picture.
Today RESONANCE HEALTH LIMITED has the market capitalization of ‪37.99 M‬, it has decreased by 6.58% over the last week.
No, RHT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RHT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESONANCE HEALTH LIMITED stock right from TradingView charts — choose your broker and connect to your account.
RHT reached its all-time high on Sep 9, 2003 with the price of 0.369 AUD, and its all-time low was 0.007 AUD and was reached on Oct 13, 2008.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESONANCE HEALTH LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESONANCE HEALTH LIMITED stock shows the buy signal. See more of RESONANCE HEALTH LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RESONANCE HEALTH LIMITED EBITDA is ‪−1.01 M‬ AUD, and current EBITDA margin is −26.98%. See more stats in RESONANCE HEALTH LIMITED financial statements.